Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-24-005896
Filing Date
2024-04-26
Accepted
2024-04-26 16:05:12
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20240429xdefa14a.htm DEFA14A 22302
2 GRAPHIC tmb-20240429xdefa14a_bg001.jpg GRAPHIC 250015
3 GRAPHIC tmb-20240429xdefa14a_bg002.jpg GRAPHIC 116148
  Complete submission text file 0001558370-24-005896.txt   527926
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40237 | Film No.: 24883519
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)